NASDAQ
GT Biopharma, Inc. (GTBP) has a fcf yield of -298.31% as of Friday, May 29, 2026. This represents a 283.27% decrease compared to its 12-month average of -77.83%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.